Star Imaging and Path Lab Ltd
Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests.[1]
- Market Cap ₹ 232 Cr.
- Current Price ₹ 133
- High / Low ₹ 151 / 123
- Stock P/E 14.6
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 33.7 %
- ROE 40.6 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 33.8%
Cons
- Company has high debtors of 227 days.
- Working capital days have increased from 45.0 days to 124 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of BSE SME IPO
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Operating Profit |
OPM % |
Interest |
Depreciation |
Profit before tax |
Tax % |
EPS in Rs |
Raw PDF |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
69 | 58 | 78 | 82 | |
54 | 52 | 56 | 53 | |
Operating Profit | 15 | 6 | 23 | 29 |
OPM % | 21% | 10% | 29% | 35% |
0 | 0 | 1 | 0 | |
Interest | 2 | 2 | 2 | 3 |
Depreciation | 4 | 3 | 5 | 5 |
Profit before tax | 9 | 1 | 16 | 21 |
Tax % | 33% | 34% | 23% | 25% |
6 | 1 | 12 | 16 | |
EPS in Rs | 42.00 | 3.80 | 82.27 | 11.79 |
Dividend Payout % | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 6% |
TTM: | 4% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 36% |
TTM: | 37% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 34% |
Last Year: | 41% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
Equity Capital | 2 | 2 | 2 | 14 |
Reserves | 17 | 17 | 30 | 34 |
30 | 27 | 31 | 33 | |
10 | 16 | 19 | 18 | |
Total Liabilities | 58 | 61 | 81 | 98 |
15 | 19 | 22 | 21 | |
CWIP | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 |
43 | 42 | 60 | 77 | |
Total Assets | 58 | 61 | 81 | 98 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
14 | 6 | 18 | -6 | |
-4 | -9 | -7 | -4 | |
-7 | -5 | 2 | -0 | |
Net Cash Flow | 3 | -7 | 13 | -10 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
Debtor Days | 86 | 110 | 151 | 227 |
Inventory Days | ||||
Days Payable | ||||
Cash Conversion Cycle | 86 | 110 | 151 | 227 |
Working Capital Days | 6 | -12 | 23 | 124 |
ROCE % | 6% | 33% | 34% |
Documents
Announcements
-
Intimation For Change Of Corporate Identification Number (CIN) And Listing Status Of Star Imaging And Path Lab Limited
4 Sep - CIN changed to L85110DL2004PLC126679; MCA listing status updated to Yes following BSE listing on 18-Aug-2025.
- Listing of Equity Shares of Star Imaging And Path Lab Ltd 18 Aug
Business Profile[1]
Star Imaging and Path Lab Limited (originally Janta X-Ray Clinic) is a Delhi-based diagnostic healthcare service provider offering pathology, radiology, cardiology, and neurology services. The company operates through B2C, B2B, and B2G models, with NABL-accredited facilities.